Clinical trial
The Efficacy of Targinact® Treatment With Respect to Quality of Life (Overall Health Assessment) in Chronic Severe Pain Patients Compared to Previous Analgesic Treatment: a Non-interventional, Observational Study.
NCT01710917 is registered in ClinicalTrials.gov with Mundipharma CVA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Targinact® Treatment With Respect to Quality of Life (Overall Health Assessment) in Chronic Severe Pain Patients Compared to Previous Analgesic Treatment: a Non-interventional, Observational Study.
- Lead sponsor
- Mundipharma CVA
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 30, 2012
- Completion date
- January 31, 2014
- Enrollment
- 1,800 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic severe pain